Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederclassic.clinicaltrials.gov
ClinicalTrials.gov: NM26-2198 | Last update posted in the last 2 days
Get the latest updates from ClinicalTrials.gov: NM26-2198 | Last update posted in the last 2 days directly as they happen.
Follow now 148 followers
Latest posts
Last updated 3 months ago
Evaluation of NM26-2198 in Healthy Subjects and in Patients With Moderate-to-severe Atopic Dermatitis (AD)
almost 2 years ago
Conditions: Atopic Dermatitis Interventions: Biological: NM26-2198; Other: Placebo Sponsors: Yellow Jersey Therapeutics...
Evaluation of NM26-2198 in Healthy Subjects and in Patients With Moderate-to-severe Atopic Dermatitis (AD)
3 months ago
Conditions: Atopic Dermatitis Interventions: Biological: NM26-2198; Other: Placebo Sponsors: Yellow Jersey Therapeutics...
Evaluation of NM26-2198 in Healthy Subjects and in Patients With Moderate-to-severe Atopic Dermatitis (AD) (updated 2025-04-03)
5 months ago
Conditions: Atopic Dermatitis Interventions: Biological: NM26-2198; Other: Placebo Sponsors: Yellow Jersey Therapeutics...
Evaluation of NM26-2198 in Healthy Subjects and in Patients With Moderate-to-severe Atopic Dermatitis (AD) (updated 2025-03-26)
5 months ago
Conditions: Atopic Dermatitis Interventions: Biological: NM26-2198; Other: Placebo Sponsors: Yellow Jersey Therapeutics...
Evaluation of NM26-2198 in Healthy Subjects and in Patients with Moderate-to-severe Atopic Dermatitis (AD) (updated 2024-11-21)
9 months ago
Conditions: Atopic Dermatitis Interventions: Biological: NM26-2198; Other: Placebo Sponsors: Numab Therapeutics AG...
Evaluation of NM26-2198 in Healthy Subjects and in Patients With Moderate-to-severe Atopic Dermatitis (AD)
over 2 years ago
Condition: Atopic DermatitisInterventions: Biological: NM26-2198; Other: PlaceboSponsors: Numab Therapeutics AG; Kaken Pharmaceutical...